手术视频
关于我们
联系我们
中心官网
泌尿系统常见疾病循证医学证据
首页
良性前列腺增生
泌尿系统感染
泌尿系统结石
前列腺炎
前列腺癌
膀胱肿瘤
肾癌
其他
首页
搜索结果
证据分类
良性前列腺增生
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
手术视频
调查问卷
泌尿系统感染
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
泌尿系统结石
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺炎
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
膀胱肿瘤
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
肾癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
其他
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
搜索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
共搜索到
111条
与
Uc
有关的结果
Diagnostic value of urodynamic bladder outlet obstruction to select patients for transurethral surgery of the prostate: Systematic review and meta-analysis
2017年 发布于
PLoS One
12卷 第2期
Kim
M. Jeong
C. W. Oh
S. J.
Aged
Humans
Male
Middle Aged
*Patient Selection
Prostate/surgery
Prostatic Hyperplasia
Quality of Life
*Transurethral Resection of Prostate
Treatment Outcome
Urinary Bladder Neck Obstruction
*Urodynamics
文献简介
原文链接
5 alpha-Reductase Inhibitors for Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
2017年 发布于
Canadian Journal of Hospital Pharmacy
70卷 第2期
Jun
J. E. J. Kinkade
A. Tung
A. C. H. Tejani
A. M.
5 alpha-Reductase Inhibitors
Benign Prostatic Hyperplasia
Meta-Analysis
文献简介
原文链接
Sexual dysfunction in subjects treated with inhibitors of 5 alpha-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis
2017年 发布于
Andrology
5卷 第4期
Corona
G. Tirabassi
G. Santi
D. Maseroli
E. Gacci
M. Dicuio
M. Sforza
A. Mannucci
E. Maggi
M.
inhibitors of 5 alpha-reductase
benign prostatic hyperplasia
meta-analysis
文献简介
原文链接
Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials
2016年 发布于
J Sex Med
13卷 第9期
Liu
L. Zhao
S. Li
F. Li
E. Kang
R. Luo
L. Luo
J. Wan
S. Zhao
Z.
5-alpha Reductase Inhibitors/*adverse effects
Drug Therapy
Combination
Ejaculation/drug effects
Erectile Dysfunction/*chemically induced/drug therapy
Finasteride
Humans
Libido/*drug effects
Male
Middle Aged
Prostatic Hyperplasia/*drug therapy
Randomized Controlled Trials as Topic
*5α-Reductase Inhibitors
*Erectile Dysfunction
*Meta-Analysis
*Sexual Dysfunction
文献简介
原文链接
Transurethral enucleation of the prostate versus transvesical open prostatectomy for large benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials
2016年 发布于
World Journal of Urology
34卷 第9期
Lin
Y. C. Wu
X. Xu
A. B. Ren
R. Zhou
X. Q. Wen
Y. Zou
Y. Gong
M. C. Liu
C. X. Su
Z. X. Herrmann
T. R. W.
Transurethral enucleation of the prostate
transvesical open prostatectomy
benign prostatic hyperplasia
meta-analysis
文献简介
原文链接
Safety and effect of transurethral holmium laser enucleation of the prostate versus bipolar transurethral plasmakinetic prostatectomy for benign prostatic hyperplasia: A meta-analysis
2016年 发布于
Zhonghua Nan Ke Xue
22卷 第10期
Guo
Q. Xiao
Y. Li
J. W. Zhang
J. D. Zhang
Y. G.
Erectile Dysfunction
Holmium
Humans
*Laser Therapy
Lasers
Solid-State
Length of Stay
Male
Prostatectomy
Prostatic Hyperplasia
Quality of Life
*Transurethral Resection of Prostate
Urethral Stricture
Urinary Bladder
Urinary Incontinence
Urinary Retention
benign prostatic hyperplasia
bipolar transurethral plasmakinetic prostatectomy
transurethral holmium laser enucleation of the prostate
文献简介
原文链接
Impact of combination therapy 5-alpha reductase inhibitors (5-ARI) plus alpha-blockers (AB) on erectile dysfunction and decrease of libido in patients with LUTS/BPH: a systematic review with meta-analysis
2016年 发布于
Aging Male
19卷 第3期
Favilla
V. Russo
G. I. Privitera
S. Castelli
T. Giardina
R. Calogero
A. E. Condorelli
R. A. La Vignera
S. Cimino
S. Morgia
G.
5-alpha reductase inhibitors
alpha-blockers
BPH
meta-analysis
文献简介
原文链接
Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials
2016年 发布于
Eur Urol Focus
2卷 第5期
Novara
G. Giannarini
G. Alcaraz
A. Cózar-Olmo
J. M. Descazeaud
A. Montorsi
F. Ficarra
V.
5α-Reductase inhibitors
Benign prostatic hyperplasia
Erectile dysfunction
Finasteride
Lower urinary tract symptoms
Meta-analysis
Permixon
Phytotherapy
Randomized controlled trial
Serenoa repens
Systematic review
Tamsulosin
α-Blockers
文献简介
原文链接
Efficacy and safety of enfortumab vedotin in the treatment of advanced urothelial carcinoma: a systematic review and meta-analysis
2023 年 发布于
Anticancer Drugs
15 卷 第 1 期
Wang L.
Shi G.
Zhao G.
He W.
Cen Z.
Xu F.
Humans
*Adjuvants
Immunologic/therapeutic use/adverse effects
Administration
Intravesical
Neoplasm Recurrence
Local/epidemiology
*Urinary Bladder Neoplasms/pathology
Drug Administration Schedule
Bcg
Cvnmi
Desabastecimiento
Dosis completa
Dosis reducida
Full dose
Nmibc
Reduced dose
Shortage
文献简介
原文链接
Postoperative Mortality Rate after Radical Cystectomy: A Systematic Review of Epidemiologic Series
2023 年 发布于
Urol Int
75 卷 第 4 期
Korkes F.
Timoteo F.
Baccaglini W.
Glina F.
Faba O. R.
Palou Redorta J.
Glina S.
Humans
Female
*Carcinoma
Transitional Cell/chemically induced/epidemiology/genetics
DNA Adducts/adverse effects
*Drugs
Chinese Herbal/adverse effects
Taiwan/epidemiology
*Urinary Bladder Neoplasms
Carcinogens
*Kidney Neoplasms/chemically induced/epidemiology/genetics
*Aristolochic Acids/adverse effects/analysis
*Ureteral Neoplasms/chemically induced/epidemiology
*Urinary Tract
Aristolochia
DNA adduct
Mass spectrometry
Nephropathy
Renal pelvic cancer
Ureteral cancer
文献简介
原文链接
Impact of Effective Intravesical Therapies on Quality of Life in Patients with Non-Muscle Invasive Bladder Cancer: A Systematic Review
2022 年 发布于
Eur Urol Focus
28 卷 第 6 期
Yuen J. W.
Wu R. W.
Ching S. S.
Ng C. F.
Biomarkers/urine
Carcinogenesis
Carcinogens/toxicity
Female
Humans
Male
*Tobacco Products/adverse effects
*Urinary Bladder Neoplasms/etiology
Biomarkers of exposure
Bladder cancer
Carcinogens
Heated tobacco product
Urine
disclosures.
文献简介
原文链接
Bladder Cancer in the Era of Immune Checkpoint Inhibitors: The Role of Pd-L1? A Meta-Analysis
2022 年 发布于
Clin Immunol
12 卷 第 1 期
Maiorano B. A.
Capone L.
Capone L.
Cisternino A.
Maiello E.
Asian People/genetics
Genetic Predisposition to Disease
Humans
*Methylenetetrahydrofolate Reductase (NADPH2)/genetics
Polymorphism
Single Nucleotide
*Urinary Bladder Neoplasms/genetics
Folate
Mthfr
Polymorphism
Urinary Neoplasms
bladder cancer
文献简介
原文链接
Optimal first-line treatment for platinum-eligible metastatic urothelial carcinoma: Comparison of chemo-immunotherapy, immunotherapy, and chemotherapy- A systematic review and meta-analysis
2022 年 发布于
Eur Urol Focus
47 卷 第 1 期
Li H.
Ni M.
Xue C.
Li L.
Huang R.
Yang W.
Hu A.
An X.
Shi Y.
Data Systems
Humans
Magnetic Resonance Imaging/methods
*Multiparametric Magnetic Resonance Imaging
Reproducibility of Results
Urinary Bladder/diagnostic imaging/pathology
*Urinary Bladder Neoplasms/diagnostic imaging/surgery
Bladder cancer
Bladder cancer staging
Multiparametric magnetic resonance imaging
Muscle-invasive bladder cancer
conflict of interest to disclose.
文献简介
原文链接
Adjuvant Radiotherapy for Upper Tract Urothelial Carcinoma: Systematic Review and Meta-Analysis
2022 年 发布于
BJU Int
8 卷 第 4 期
Zalay O.
Yan M.
Sigurdson S.
Malone S.
Vera-Badillo F. E.
Mahmud A.
Biomarkers
Tumor
*Carcinoma
Transitional Cell/diagnosis
Female
Humans
Male
Nuclear Proteins
Sensitivity and Specificity
*Urinary Bladder Neoplasms/diagnosis/pathology
bladder tumor
diagnosis
meta analysis
nuclear matrix protein
urine cytology
文献简介
原文链接
Inter-reader reliability of the vesical imaging-reporting and data system (VI-RADS) for muscle-invasive bladder cancer: a systematic review and meta-analysis
2022 年 发布于
Bladder Cancer
2022 卷 第 5 期
Jazayeri S. B.
Dehghanbanadaki H.
Hosseini M.
Taghipour P.
Bazargani S.
Thomas D.
Feibus A.
Sarabchian E.
Bacchus M. W.
Di Valerio E. A.
Bandyk M.
Balaji K. C.
Area Under Curve
*Carcinoma
Transitional Cell
Humans
In Situ Hybridization
Fluorescence
ROC Curve
Sensitivity and Specificity
*Urinary Bladder Neoplasms/pathology
Biomarker
Cytology
Diagnostic
Fluorescent in situ hybridization (FISH)
Meta-analysis
Upper urinary tract urothelial carcinoma (UTUC)
文献简介
原文链接
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review
2022 年 发布于
Epidemiol Health
24 卷 第 2 期
Barone B.
Calogero A.
Scafuri L.
Ferro M.
Lucarelli G.
Di Zazzo E.
Sicignano E.
Falcone A.
Romano L.
De Luca L.
Oliva F.
Mirto B. F.
Capone F.
Imbimbo C.
Crocetto F.
Carcinoma
Transitional Cell/*pathology/*surgery
Humans
Kidney Neoplasms/*pathology
Neoplasms
Second Primary/*pathology
Nephrotomy
Risk Factors
Stents/*adverse effects
Ureteral Obstruction/etiology/*surgery
Urinary Bladder Neoplasms/*pathology/*surgery
carcinoma
transitional cell
hydronephrosis
meta-analysis
stents
urinary bladder neoplasms
文献简介
原文链接
Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR)
2022 年 发布于
Eur Urol Focus
236 卷 第 2 期
Musat M. G.
Kwon C. S.
Masters E.
Sikirica S.
Pijush D. B.
Forsythe A.
Humans
Male
*Urinary Bladder Neoplasms
Reproducibility of Results
ROC Curve
Image Interpretation
Computer-Assisted
Muscles
Magnetic Resonance Imaging
Retrospective Studies
Bladder cancer
Inter-reader agreement
Meta-analysis
Reliability
Vi-rads
文献简介
原文链接
French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC)
2022 年 发布于
Prog Urol
32 卷 第 15 期
Neuzillet Y.
Pradère B.
Xylinas E.
Allory Y.
Audenet F.
Loriot Y.
Masson-Lecomte A.
Roumiguié M.
Seisen T.
Traxer O.
Leon P.
Roupret M.
Humans
*Carcinoma
Transitional Cell/diagnosis/therapy
*Urinary Bladder Neoplasms
Systematic Reviews as Topic
Kidney
Oregon
*Ureteral Neoplasms/diagnosis/therapy
Utuc
renal pelvis cancer
upper tract urothelial cancer
ureteral cancer
urothelial cancer
文献简介
原文链接
新辅助化疗治疗肌层浸润性膀胱癌疗效及安全性的 Meta 分析
2022 年 发布于
Front Immunol
32 卷 第 Pt 3 期
窦新猛
bladder cancer
cohort
cruciferous vegetables
meta-analysis
risk
commercial or financial relationships that could be construed as a potential
conflict of interest.
文献简介
原文链接
[Expert consensus of multi-disciplinary collaboration on bladder-preserving treatment for bladder cancer in China]
2022 年 发布于
Zhonghua Zhong Liu Za Zhi
44 卷 第 3 期
Urological Chinese Oncology Group
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
*Carcinoma
Transitional Cell/pathology
Cisplatin/therapeutic use
Cystectomy
Humans
Muscles/pathology
Neoadjuvant Therapy
Neoplasm Invasiveness
*Urinary Bladder Neoplasms/pathology
Bladder cancer
Muscle-invasive
Urothelial
from MSD and BMS and Speaker and Other from AstraZecena. BPV reports Advisory
Board
Speaker and Other from Astellas
Roche
BMS and Merk-Pfizer
Advisory
Board and Other from Ipsen
Advisory Board and Speaker from EUSA and MSD and
Advisory Board from Sanofi. IPF report Advisory Board
Speaker and Other from
Pfizer
Speaker and Other from Ipsen and Roche
Advisory Board from EUSA and BMS
and Speaker from Novartis and MSD. OFC reports Advisory Board and Speaker from
Ipsen and Astellas
Advisory Board from BMS and Pfizer-Merck and Speaker from
AstraZeneca. AGA has received research funding from Astellas
travel grants from
Astellas
Jansen
Sanofi
BMS
Roche
Pfizer and Ipsen and honoraria for speaker
engagements
advisory boards and continuous medical education from Janssen
Astellas
Sanofi
Bayer
Roche
Ipsen
BMS
MSD
Pfizer
Eusa Pharma
Eisai and
AstraZeneca. JAA reports honoraria from Astellas
Pfizer and BMS
conulting or
advisory role from Pfizer
Astellas
Janssen-Cilag
MSD Oncology
BMS
Merck
AstraZeneca
Bayer and Eisai and Research Funding from BMS. RMB
SVE
CCD and MDS
have nothing to disclose.
文献简介
原文链接
首页
上一页
1
2
3
4
5
6
下一页
尾页
共111条,每页显示
20条
50条
100条
跳转至第
页
确定